Ignite Creation Date:
2025-12-24 @ 11:31 PM
Ignite Modification Date:
2026-01-01 @ 5:43 AM
Study NCT ID:
NCT02021656
Status:
COMPLETED
Last Update Posted:
2020-03-05
First Post:
2013-12-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Participants With Chronic Genotype 1 HCV Infection
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-12-10
Start Date Type:
ACTUAL
Primary Completion Date:
2017-07-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09-29
Completion Date Type:
ACTUAL
First Submit Date:
2013-12-20
First Submit QC Date:
None
Study First Post Date:
2013-12-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-07-03
Results First Submit QC Date:
None
Results First Post Date:
2018-12-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-18
Last Update Post Date:
2020-03-05
Last Update Post Date Type:
ACTUAL